哈尔滨敷尔佳科技股份有限公司 互动易平台信息发布及回复内部审核制度 第一章 总则 第一条 为规范哈尔滨敷尔佳科技股份有限公司（以下简称"公司"）互动 易平台信息发布及回复的管理工作，建立公司与投资者良好沟通机制，持续提升 公司治理水平，根据中国证监会《上市公司信息披露管理办法》《上市公司投资 者关系管理工作指引》以及《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作》等法律法规及《公司章程》的规定，制定本制度。 第二条 本制度所指"互动易平台"是指深圳证券交易所为上市公司与投资 者之间搭建的自愿性、交互式信息发布和进行投资者关系管理的综合性网络平台， 是上市公司法定信息披露的有益补充。 第三条 互动易平台发布信息及回复的总体要求： 公司在互动易平台发布信息及回复投资者提问时，应当注重诚信，尊重并平 等对待所有投资者，主动加强与投资者的沟通，增进投资者对公司的了解和认同， 营造健康良好的市场生态。 公司在互动易平台发布信息及回复投资者提问时，应当谨慎、理性、客观， 以事实为依据，保证所发布信息的真实、准确、完整和公平，不得使用夸大性、 宣传性、误导性语言，应当注重与投资者交流互动的效果， ...

证券代码：301371 证券简称：敷尔佳 公告编号：2025-038 哈尔滨敷尔佳科技股份有限公司 关于变更财务负责人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、财务负责人辞任的情况 哈尔滨敷尔佳科技股份有限公司（以下简称"公司"）董事会于 2025 年 9 月 23 日收到公司董事、董事会秘书、财务负责人邓百娇女士提交的《辞任报告》， 邓百娇女士因岗位职责调整，申请辞去财务负责人职务，其原定任期至第二届董 事会届满之日止，辞去财务负责人职务后将继续担任公司董事、董事会秘书职务。 根据《公司法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》《公司章程》等相关规定，邓百娇女士的《辞任报告》自送达公 司董事会之日起生效。 邓百娇女士在担任公司财务负责人期间勤勉尽责、恪尽职守，忠实履行了财 务负责人的职责与义务，为促进公司规范运作发挥了积极作用，公司及公司董事 会对邓百娇女士担任财务负责人期间为公司所作出的贡献表示衷心的感谢！ 截至本公告披露日，公司董事、董事会秘书邓百娇女士持有公司股份 455,000 股，占公司总股本 ...

哈尔滨敷尔佳科技股份有限公司 子公司管理制度 第一章 总则 第一条 为加强对哈尔滨敷尔佳科技股份有限公司（以下简称"公司"）子 公司的管理，有效控制经营风险，保护投资者合法权益，根据《中华人民共和国 公司法》（以下简称"《公司法》"）《中华人民共和国证券法》等法律法规及 《哈尔滨敷尔佳科技股份有限公司章程》（以下简称"《公司章程》"）的有关 规定，制定本制度。 第二条 本制度所称子公司为公司合并报表范围内的公司，指公司依法设立 或收购的、具有独立法人资格的公司。 第三条 公司通过向子公司委派董事、监事及高级管理人员和加强日常监管 两条途径行使股东权利，并负有对子公司指导、监督职责和相关服务的义务。 （四）公司内审部主要负责对子公司重大事项和规范运作进行审计监督。 第二章 规范运作 第六条 子公司可以依据《公司法》等有关法律法规，完善自身的法人治理 1 结构，建立健全内部管理制度和三会制度。子公司依法设立股东会、董事会（如 有，或执行董事）、监事会（如有，或监事）。 第七条 子公司的董事、监事及高级管理人员具有以下职责： 第四条 子公司在公司授权范围内，可以根据自身经营特点和环境条件，制 定其内部控制制度。子公 ...

证券代码：301371 证券简称：敷尔佳 公告编号：2025-037 哈尔滨敷尔佳科技股份有限公司 第二届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1、审议通过《关于聘任财务负责人的议案》 经董事会审查，李政德先生具备担任财务负责人相应的专业知识与工作经验， 具备担任上市公司财务负责人的能力，任职资格符合上市公司财务负责人的任职条 件，不存在《公司法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》《公司章程》中规定禁止任职的条件，不存在损害公司及其他 股东特别是中小股东利益的情形。同意聘任李政德先生为公司财务负责人，任期自 本次董事会审议通过之日起至第二届董事会届满之日止。 具体内容详见公司同日刊登在巨潮资讯网（www.cninfo.com.cn）上的相关公告。 表决结果：同意 6 票，反对 0 票，弃权 0 票。 本议案已经公司董事会审计委员会、提名委员会审议通过。 2、审议通过《关于制定<子公司管理制度>的议案》 一、董事会会议召开情况 哈尔滨敷尔佳科技股份有限公司（以下简称"公司"）第二届董 ...

Market Overview - On September 25, the cosmetics sector declined by 0.34%, with Jiaheng Jiahua leading the drop [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Individual Stock Performance - Notable gainers included: - Jinsheng New Material (300849) with a closing price of 13.42, up 1.82% [1] - Tiancaiya (603605) with a closing price of 80.50, up 1.31% [1] - Major decliners included: - Jiaheng Jiahua (300955) with a closing price of 27.90, down 2.04% [2] - Wanmei Biological (603983) with a closing price of 39.81, down 1.87% [2] Trading Volume and Capital Flow - The cosmetics sector experienced a net outflow of 49.89 million yuan from main funds, while retail investors saw a net inflow of 29.38 million yuan [2] - The trading volume for key stocks included: - Shanghai Jahwa (600315) with a trading volume of 37,100 shares and a turnover of approximately 96.45 million yuan [1] - Qingdao Kingway (002094) with a trading volume of 167,200 shares and a turnover of approximately 130 million yuan [2] Fund Flow Analysis - Main fund inflows and outflows for selected stocks: - Shanghai Jahwa had a main fund net inflow of 3.17 million yuan, while retail investors contributed a net inflow of 3.43 million yuan [3] - Jiaheng Jiahua saw a main fund net outflow of 393,800 yuan, with retail investors contributing a net outflow of 387,720 yuan [3]

Core Viewpoint - The company is focusing on enhancing its research and development capabilities by leveraging talent from Harbin Institute of Technology and expanding its R&D teams in multiple locations [1] Group 1: R&D Strategy - The company has established R&D centers in Harbin and Shanghai, creating a collaborative research system [1] - The current scale of the R&D team is steadily expanding, with ongoing efforts to build a core technical talent pipeline [1] - Future plans include increasing the recruitment and training of high-end R&D talent to improve team expertise and innovation capabilities [1] Group 2: Development Goals - The company aims to strengthen its core R&D capabilities to support technological breakthroughs and product iterations [1] - Suggestions from investors will be considered in the company's development strategy to promote high-quality growth of the R&D system [1]

Core Viewpoint - The company Fuhua Jia experienced a decline in stock price and trading volume, with significant changes in financing and shareholder structure, indicating potential challenges in its financial performance and market position [1][2][3]. Financing Summary - On September 23, Fuhua Jia's stock price fell by 2.12%, with a trading volume of 47.50 million yuan. The financing buy-in amount was 4.99 million yuan, while the financing repayment was 7.16 million yuan, resulting in a net financing buy-in of -2.16 million yuan. The total financing and securities balance reached 101 million yuan [1]. - The current financing balance of 101 million yuan accounts for 5.12% of the circulating market value, which is below the 20th percentile level over the past year, indicating a low financing level [1]. - In terms of securities lending, Fuhua Jia repaid 300 shares and sold 3,700 shares on September 23, with a selling amount of 90,700 yuan. The remaining securities lending volume was 15,700 shares, with a balance of 384,500 yuan, which is above the 70th percentile level over the past year, indicating a high level [1]. Financial Performance Summary - For the first half of 2025, Fuhua Jia reported an operating income of 863 million yuan, a year-on-year decrease of 8.15%. The net profit attributable to the parent company was 230 million yuan, down 32.54% year-on-year [2]. - Since its A-share listing, Fuhua Jia has distributed a total of 1 billion yuan in dividends [3]. Shareholder Structure Summary - As of September 19, the number of shareholders for Fuhua Jia was 15,000, a decrease of 5.99% from the previous period. The average circulating shares per person increased by 6.37% to 5,166 shares [2]. - As of June 30, 2025, among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF ranked as the second-largest shareholder with 2.55 million shares, an increase of 655,700 shares from the previous period. New entrants included Guangfa Pension Index A and Huaxia Zhongzheng 1000 ETF [3].

证券日报网讯敷尔佳（301371）9月23日发布公告，在公司回答调研者提问时表示，销售渠道优化工作 是持续、动态开展的，上半年已取得阶段性进展，销售渠道逐渐回归健康，今年第二季度营业收入环比 增长86.68%，业绩呈回暖趋势，进展符合公司预期。 ...

Core Viewpoint - The company, Fulejia, announced on September 23 that its products are primarily divided into two categories: medical devices and functional skincare products, featuring a diverse range of formulations including masks, waters, serums, lotions, sprays, single-use products, and eye masks [2] Group 1 - The company offers a wide variety of product forms, which enhances its market coverage [2] - The product categories include both medical devices and functional skincare, indicating a diversified product portfolio [2]

Group 1 - The core viewpoint of the article highlights the successful collaboration between the company and JD.com, which has led to a significant increase in product variety on JD's platform [2] - The company has implemented new cooperative strategies such as promotional activities and new product launches, contributing to JD.com's growth [2] - The announcement was made during a response to inquiries from researchers, emphasizing the positive performance observed in the first half of the year [2]